Coronavirus

Routine screening of employees at St. Jude Children’s Research Hospital show lower rates of asymptomatic SARS-CoV-2 infection among vaccinated workers.

There is still much to understand in the cases for those who did not require hospitalization but have lingering symptoms that can cause quality-of-life issues.

An investigational therapy demonstrated neutralizing antibodies as well as protection against the virus in preclinical trials.

A diagnostic analyzer was studied looking at 3 biomarkers to predict the level of COVID-19, and could potentially serve as a risk stratification tool.

A majority of the study participants experienced symptoms that interfered with activities of their daily life.

The IL-6 targeting monoclonal antibody is linked to improved inflammatory and hemodynamic markers in hospitalized patients.

A concerted effort to increase flu vaccination during the COVID-19 pandemic resulted in more protection among a high-risk population, as well as educational opportunities for pharmacy students.

The federal agency elongates the time from 5 days up to 1 month for thawed out doses of the Pfizer-BioNTech vaccine.

Kits created by companies like Cepheid and bioMérieux will aid in the testing and treatment of viral infections in the future.

Children who experienced MIS-C showed an elevation of certain adaptive immune responses that confer immunological memory.

Patients who received the therapy had half the rate of mortality at 28 days after treatment.

The European Union (EU) agrees to look at easing restrictions for travelers from outside the continent, depending on vaccine or country status.

Studies are in early stages, according to the scientists at Rensselaer Polytechnic Institute (RPI) leading them.

The nanofiber filter was able to remove 99.9% of the coronavirus aerosols, while cotton masks only removed 45%-73%.

The novel sensor system is able to detect the presence of a virus in just 1 second.

Patients who were most likely to suffer complications and received the therapy had a 60% reduced chance of hospitalization and death.

A Roche test can be used in individuals not showing signs of symptomatic disease.

A new CDC study demonstrates effectiveness in a population with high exposure to the virus.

Mumbai and Gujarat suspend vaccination drives due to tropical cyclone Tauktae.

Interim results showed the candidate triggered strong immune responses in the participants with a 95% to 100% seroconversion rate.

As pre-existing conditions like diabetes are linked to more severe COVID-19, neurological symptoms could portend higher risk of in-hospital death.

The success of the US effort to tamp down the virus with testing and vaccination cannot blind us to the situation in the rest of the world.

A discussion with William Schaffner surrounding the CDC recently updating their recommendations on mask wearing.

Certain genes that were identified have been implicated in other respiratory illness like asthma.

A small group of patients with antibody deficiencies were able to mount an immune response to COVID-19.

With yesterday’s announcement, a lot of questions remain about how to proceed. One expert weighs in on this significant topic including how masks have substantially helped as a COVID-19 prevention strategy.

Many patients in the study showed symptoms including vomiting, diarrhea, muscle pain and a rash.

Investigators in the United Kingdom modeled the comparative risk of death from COVID-19 and the B.1.1.7 variant.

AP source says CDC will make an announcement Thursday regarding indoor and outdoor masking.

Two air cleaning systems placed close to each other resulted in the best filtration, lowering the risk of viral transmission.